http://alsfindingacure.org/images/homepage/slider/slide-1.jpg
    • Leandro P. Rizzuto  Chairman in Perpetuity
    • Peter N. Foss  President, Advisory Board
    • Merit Cudkowicz MD Chief Medical Officer
    • Stanley H. Appel MD Advisory Board Member
    • Robert Brown D.Phil., MD Advisory Board Member
    • Tom Gentile  Advisory Board Member
    • Clive Svendsen PhD Advisory Board Member
    • Richard Ellenbogen MD Advisory Board Member
    • Randy Fishman  Advisory Board Member
    • Edward J. Rapp  Advisory Board Member
  • X

    Clive  Svendsen PhD

    Advisory Board Member

    Dr. Clive Svendsen is Director of the Cedars-Sinai Regenerative Medicine Institute, Professor in Residence at UCLA and Consulting Professor at Stanford University. He did his pre-doctoral training at Harvard University and received his PhD from the University of Cambridge in England, where he then established a stem cell research group before moving to the University of Wisconsin in 2000 to become Professor of Neurology and Anatomy, Director of an NIH-funded Stem Cell Training Program and Co-Director of the University of Wisconsin Stem Cell and Regenerative Medicine Center.

    In 2010 he moved to Los Angeles to establish and direct the Cedars-Sinai Regenerative Medicine Institute that currently has 15 faculty members and approximately 100 staff. Dr. Svendsen has worked with human neural stem cells for over 20 years - showing that they can survive and integrate into the brains of many different animal models of disease, including ALS, Parkinson's, Huntington's and stroke.

    He has also had four recent key papers in the field of modeling neurological diseases using induced pluripotent stem cells. The first, showing specific death of motor neurons from children with spinal muscular atrophy (Nature 2009); the second, showing neuronal changes in neurons generated from patients with Huntington's Disease (Cell Stem Cell 2012); and the third, showing phenotypic changes in neurons generated from patients with ALS (Science Translational Medicine, 2013).

    The other side of his research involves cutting-edge clinical trials. He was the driving force behind one of the first growth factor treatments for Parkinson's disease (Nature Medicine, 2003) and is currently working closely with neurosurgeons and neurologists to develop novel ways of using stem cells modified to release powerful growth factors to treat patients with neurological diseases such as ALS, Huntington's, Alzheimer's and Parkinson's.

    He is currently the principal investigator on an $18M state grant that will take stem cells releasing growth factors to the clinic for ALS. He has won numerous scientific awards, including the 2005 Bernard Sandbeg Memorial Award for Brain Repair, the 2009 Trailblazer Award from the Huntington's Disease Society of America and the 2010 Sheila Essey Award for ALS Research from the American Academy of Neurology.

A Program Of

Advisory Board

  • Leandro P. Rizzuto
  • Peter N. Foss
  • Merit  Cudkowicz, MD
  • Denis  Rizzuto
  • Stanley H. Appel, MD
  • Robert  Brown, D.Phil., MD
  • Tom  Gentile
  • Clive  Svendsen, PhD
  • Richard  Ellenbogen, MD
  • Randy  Fishman
  • Edward J. Rapp